| 000 | 01199 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515030810.0 | ||
| 264 | 0 | _c20061103 | |
| 008 | 200611s 0 0 eng d | ||
| 022 | _a0114-5916 | ||
| 024 | 7 |
_a10.2165/00002018-200629060-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTchambaz, Lydia | |
| 245 | 0 | 0 |
_aDose adaptation of antineoplastic drugs in patients with liver disease. _h[electronic resource] |
| 260 |
_bDrug safety _c2006 |
||
| 300 |
_a509-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 |
_aLiver Diseases _xmetabolism |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aSchlatter, Chantal | |
| 700 | 1 | _aJakob, Max | |
| 700 | 1 | _aKrähenbühl, Anita | |
| 700 | 1 | _aWolf, Peter | |
| 700 | 1 | _aKrähenbühl, Stephan | |
| 773 | 0 |
_tDrug safety _gvol. 29 _gno. 6 _gp. 509-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00002018-200629060-00004 _zAvailable from publisher's website |
| 999 |
_c16349362 _d16349362 |
||